Evidence map›Paper›PMID 34120510›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making2021

Maximizing the Efficiency of Active Case Finding for SARS-CoV-2 Using Bandit Algorithms.

Gregg S Gonsalves, J Tyler Copple, A David Paltiel, Eli P Fenichel, Jude Bayham, Mark Abraham, David Kline, Sam Malloy, Michael F Rayo, Net Zhang and 6 more

Open access · greenAbstract read
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Integrating testing volume into bandit algorithms for infectious disease surveillance.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Gregg S GonsalvesDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.ORCID 0000-0002-5789-9841
J Tyler CoppleDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
A David PaltielDepartment of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
Eli P FenichelYale School of the Environment, New Haven, CT, USA.
Jude BayhamDepartment of Agricultural and Resource Economics, Colorado State University, Fort Collins, CO, USA.
Mark AbrahamDataHaven, New Haven, CT, USA.
David KlineCenter for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
Sam MalloyBattelle Center for Science, Engineering, and Public Policy, John Glenn College of Public Affairs, The Ohio State University, Columbus, OH, USA.
Michael F RayoIntegrated Systems Engineering, The Ohio State University, Columbus, OH, USA.
Net ZhangBattelle Center for Science, Engineering, and Public Policy, John Glenn College of Public Affairs, The Ohio State University, Columbus, OH, USA.
Daria FaulknerCollege of Public Health, The Ohio State University, Columbus, OH, USA.
Dane A MoreyIntegrated Systems Engineering, The Ohio State University, Columbus, OH, USA.
Frank WuDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Thomas ThornhillDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Suzan IlogluDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.ORCID 0000-0003-1611-9850
Joshua L WarrenDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Yale University · USThe Ohio State University · USBattelle · USBiohaven Pharmaceuticals (United States) · USColorado State University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Making Better Decisions: Policy Modeling for AIDS and Drug AbuseR01DA015612 · NIDA · STANFORD UNIVERSITY · PI OWENS, DOUGLAS K · 2002 to 2017
$9.4M
Making Better Decisions: Policy Modeling for AIDS and Drug AbuseR37DA015612 · NIDA · STANFORD UNIVERSITY · PI DOUGLAS K OWENS · 2019 to 2026
$6.3M
Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countriesR01AI112970 · NIAID · YALE UNIVERSITY · PI PITZER, VIRGINIA E · 2015 to 2024
$4.1M
Predicting and monitoring variations in the effects of vaccines against RSVR01AI137093 · NIAID · YALE UNIVERSITY · PI Virginia E Pitzer, Daniel Martin Weinberger · 2018 to 2026
$3.4M
Novel, Adaptive Approaches to Predicting and Responding to Outbreaks of Overdose, HIV and HCV Among People Who Use DrugsDP2DA049282 · NIDA · YALE UNIVERSITY · PI GONSALVES, GREGG STEVEN · 2019 to 2019
$2.5M
NCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI112970NIAID NIH HHS R01 AI137093NIDA NIH HHS DP2 DA049282NIDA NIH HHS R01 DA015612NIDA NIH HHS R37 DA015612
6 · The paper itself

Abstract

Even as vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) expands in the United States, cases will linger among unvaccinated individuals for at least the next year, allowing the spread of the coronavirus to continue in communities across the country. Detecting these infections, particularly asymptomatic ones, is critical to stemming further transmission of the virus in the months ahead. This will require active surveillance efforts in which these undetected cases are proactively sought out rather than waiting for individuals to present to testing sites for diagnosis. However, finding these pockets of asymptomatic cases (i.e., hotspots) is akin to searching for needles in a haystack as choosing where and when to test within communities is hampered by a lack of epidemiological information to guide decision makers' allocation of these resources. Making sequential decisions with partial information is a classic problem in decision science, the explore v. exploit dilemma. Using methods-bandit algorithms-similar to those used to search for other kinds of lost or hidden objects, from downed aircraft or underground oil deposits, we can address the explore v. exploit tradeoff facing active surveillance efforts and optimize the deployment of mobile testing resources to maximize the yield of new SARS-CoV-2 diagnoses. These bandit algorithms can be implemented easily as a guide to active case finding for SARS-CoV-2. A simple Thompson sampling algorithm and an extension of it to integrate spatial correlation in the data are now embedded in a fully functional prototype of a web app to allow policymakers to use either of these algorithms to target SARS-CoV-2 testing. In this instance, potential testing locations were identified by using mobility data from UberMedia to target high-frequency venues in Columbus, Ohio, as part of a planned feasibility study of the algorithms in the field. However, it is easily adaptable to other jurisdictions, requiring only a set of candidate test locations with point-to-point distances between all locations, whether or not mobility data are integrated into decision making in choosing places to test.

Indexed as

COVID-19SARS-CoV-2AlgorithmsCOVID-19 TestingHumansbandit algorithmsreinforcement learningSARS-CoV-2surveillancetesting

Identifiers

PMID34120510
PMCPMC8484027
OpenAlexW3168577360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.